← Back to Search

Placebo

Vitamin D (4000 IU) for Vitamin D

N/A
Waitlist Available
Led By Wesley Bonam, BSc, MBBS, FAIMS, MRSH
Research Sponsored by Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year

Summary

This trial will test whether vitamin D supplementation can improve immunological outcomes for patients with tuberculosis.

Eligible Conditions
  • Vitamin D
  • Immunity
  • Tuberculosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cell-mediated immunological markers
Immune function
Vitamin D status
Secondary study objectives
HIV disease progression
TB treatment outcomes

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Vitamin D (600 IU)Experimental Treatment1 Intervention
Group II: Vitamin D (4000 IU)Experimental Treatment1 Intervention
Group III: Vitamin D (2000 IU)Experimental Treatment1 Intervention
Group IV: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Arogyavaram Medical CentreOTHER
3 Previous Clinical Trials
3,200 Total Patients Enrolled
Cornell UniversityLead Sponsor
171 Previous Clinical Trials
14,088,993 Total Patients Enrolled
Wesley Bonam, BSc, MBBS, FAIMS, MRSHPrincipal InvestigatorArogyavaram Medical Centre (India)
~45 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top